In Reply to Gultekin and Yildiz

Jérôme Doyen; Danny Jazmati; Dirk Geismar; Sabine Frisch; Stefanie Schulze Schleithoff; Xavier Vermeren; Monika Scheer; Christoph Blasé; Stephan Tippelt; Beate Timmermann

doi:10.1016/j.ijrobp.2019.09.032

In Reply to Gultekin and Yildiz

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1164-1165. doi: 10.1016/j.ijrobp.2019.09.032.

Authors

Affiliations

¹ Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany; Department of Radiation Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Fédération Claude Lalanne, Nice, France.
² Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany.
³ Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany; German Cancer Consortium (DKTK).
⁴ Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany.
⁵ West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), University Hospital Essen, Essen, Germany.
⁶ Pediatrics 5 (Oncology, Hematology, Immunology), Olgahospital, Klinikum Stuttgart, Stuttgart, Germany; Cooperative Weichteilsarkomstudiengruppe (CWS).
⁷ Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; AnästhesieNetz Rhein-Ruhr, Bochum, Germany.
⁸ Department of Pediatric Oncology and Hematology, Pediatrics III, University Hospital Essen, Essen, Germany.
⁹ Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; German Cancer Consortium (DKTK).

PMID: 31748140
DOI: 10.1016/j.ijrobp.2019.09.032

No abstract available

Publication types

Letter
Comment

MeSH terms

Child
Chronic Disease
Humans
Neoplasm Recurrence, Local
Proton Therapy*
Rhabdomyosarcoma, Embryonal*